ArticleAmerican journal of preventive medicine2025
Changes in Price, Consumption, Prevalence, and State Revenue of Transitioning Cigarette Sales to State-Controlled Outlets.
Article in American journal of preventive medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
introductionPolicies that phase out the retail sale of tobacco products have been recommended to accelerate the tobacco endgame and reach negligible tobacco use rates. Using simulation modeling, this study assessed how a policy that transitions cigarette sales to state-controlled outlets may change prices and thus affect state revenue, cigarette pack sales, and smoking prevalence.
methodsUsing data from the Behavioral Risk Factor Surveillance System and Tax Burden On Tobacco, models were developed to examine 3 potential scenarios resulting from a policy that transitions the sales of cigarette products to state-controlled outlets in Oregon, Pennsylvania, Vermont, and Virginia. In Model 1, each state would keep cigarette pack prices at their current retail price but retain markup; in Model 2, cigarette pack prices would increase by 7%; and in Model 3, each state would increase prices to meet a consumption target reduction of 5%. For each price scenario, additional models that also considered changes to consumer travel and time costs were run.
resultsAcross all models, state revenue increased in each state. Results suggest that the policy would increase revenue by at least 16% in Oregon to 302% in Virginia. In models that assumed that the cigarette pack price would increase, cigarette pack consumption and smoking prevalence declined. Declines in pack consumption and smoking prevalence ranged from 1% to 5% across states. Findings were robust to different assumptions about total own-price elasticities in sensitivity analyses.
conclusionsTransitioning cigarette sales to state-controlled outlets may increase state revenue while reducing cigarette consumption and smoking prevalence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.